Taxus Cardium Target Price vs. Retained Earnings

CRXMDelisted Stock  USD 0.0001  0.00  0.00%   
Taking into consideration Taxus Cardium's profitability measurements, Taxus Cardium Pharmaceuticals may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in February. Profitability indicators assess Taxus Cardium's ability to earn profits and add value for shareholders.
For Taxus Cardium profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Taxus Cardium to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Taxus Cardium Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Taxus Cardium's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Taxus Cardium Pharmaceuticals over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Please note, there is a significant difference between Taxus Cardium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taxus Cardium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taxus Cardium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Taxus Cardium Pharma Retained Earnings vs. Target Price Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Taxus Cardium's current stock value. Our valuation model uses many indicators to compare Taxus Cardium value to that of its competitors to determine the firm's financial worth.
Taxus Cardium Pharmaceuticals is currently under evaluation in target price category among its peers. It is number one stock in retained earnings category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Taxus Cardium's earnings, one of the primary drivers of an investment's value.

Taxus Retained Earnings vs. Target Price

Taxus Cardium

 = 
2.0
Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Taxus Cardium

Retained Earnings

 = 

Beginning RE + Income

-

Dividends

 = 
(114.05 M)
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.

Taxus Retained Earnings Comparison

Taxus Cardium is currently under evaluation in retained earnings category among its peers.

Taxus Cardium Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Taxus Cardium, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Taxus Cardium will eventually generate negative long term returns. The profitability progress is the general direction of Taxus Cardium's change in net profit over the period of time. It can combine multiple indicators of Taxus Cardium, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. Gene Biotherapeutics, Inc. was incorporated in 2003 and is headquartered in San Diego, California. Taxus Cardium operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.

Taxus Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Taxus Cardium. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Taxus Cardium position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Taxus Cardium's important profitability drivers and their relationship over time.

Use Taxus Cardium in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Taxus Cardium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taxus Cardium will appreciate offsetting losses from the drop in the long position's value.

Taxus Cardium Pair Trading

Taxus Cardium Pharmaceuticals Pair Trading Analysis

The ability to find closely correlated positions to Taxus Cardium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Taxus Cardium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Taxus Cardium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Taxus Cardium Pharmaceuticals to buy it.
The correlation of Taxus Cardium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Taxus Cardium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Taxus Cardium Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Taxus Cardium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Taxus Cardium position

In addition to having Taxus Cardium in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Emerging Markets ETFs Thematic Idea Now

Emerging Markets ETFs
Emerging Markets ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Emerging Markets ETFs theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Consideration for investing in Taxus Pink Sheet

If you are still planning to invest in Taxus Cardium Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taxus Cardium's history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world